A free, weekly newsletter dedicated to keeping you up to date on all things mushroom. We sum up the news, breakthroughs and the fun in a quick, 5 min read!
We're back after a two-year break.
Therapeutics, the business of Mushrooms, and transformative studies and stories delivered daily!
We have some exciting announcements, podcasts and partnerships coming to https://t.co/2jzR8vbIXP!
Join our Newsletter/Community today!🍄🌞👇🤲
🚨The Daily Mushroom is Live!!! @DailyMushroom1 is North America's #1 mushroom psilocybin newsletter.
Subscribe/follow now!
Stay up-to-date with a curated selection of studies, breaking news, and the business of psychedelics!
👇👇👇
https://t.co/9EEvrpFNxc
🍄We're incredibly proud to re-launch North America's #1 Mushroom/Psilocybin newsletter community!
Transformative stories, evidence-based studies/breakthroughs, and brands you can trust.
Subscribe today and "Let's Have Fun In There!"
https://t.co/ORumsm3mkE
It takes courage to help yourself.
It takes next nevel courage to introduce others to solutions for PTSD, Anxiety, CTE, depression, etc.
What Dan is doing is groundbreaking. Follow @CarBombBoom13.
It takes courage to help yourself.
It takes next nevel courage to introduce others to solutions for PTSD, Anxiety, CTE, depression, etc.
What Dan is doing is groundbreaking. Follow @CarBombBoom13.
There have been over 5000 clients that have been served mushrooms in Oregon
It's the largest clinical trial on earth and it's with natural, full spectrum medicine
I am excited to announce we hit another milestone yesterday in our journey to getting our 1st center open in Portland
By collecting important outcome data, we will differentiate ourselves and provide valuable information regarding the treatment of different addictions, behavioral, psychiatric and neurological disorders
To learn more information about the healing power of mushrooms, our upcoming LEGAL mushroom retreats in Oregon & to join the weekly webinars & email list, please email me at [email protected]
Onward
The DailyMushroom is FULL of transformational stories like @CarBombBoom13.
Dan Carcillo i all of us. People who find miracles in other people's bravery and advocate for their physical, emotional, and mental well-being.
Join our community today! 👇🍄
https://t.co/2jzR8vbIXP
Some before and after snapshots following a 10 year - 164 @NHL fight career, 7 diagnosed concussions, 2 Stanley Cups and a neurodegenerative disease diagnosis in 2015 at the age of 30
I was an extreme case of post concussion syndrome, suffering from slurred speech, headache, head pressure, insomnia, impulse control issues, short & long term memory loss, in top of anxiety, depression and suicidal ideation
If I can get better using a natural mushroom regimen, and you are suffering from concussion related symptoms, I know you can too
Onward
We're thrilled to bring https://t.co/JvB80pZT8L back after a two-year break.
Dean's story is so familiar to us. We're grateful for every member of our community newsletter who courageously shares transformative stories with us.🙏
#Mushrooms#Community
☀️Partnering with North America's number-one Mushroom Newsletter was a no-brainer.
The emerging solutions behind psychedelic and nonpsychedelic mushrooms to the business of miracles.
Join the most robust community in North America and get busy getting better. 🍄🙏👇
Proud to be partners with @DailyMushroom1 - the most comprehensive resource of all things Mushroom.
From business to peer review studies, transformative stories of relief, breakthroughs, and renewed hope, join https://t.co/14ZZTk0WNA community today. 🍄🌞
"The Art, Science, and Business of Mushrooms."
We summarize the news, breakthroughs, and fun in a quick, 5-minute read delivered to your inbox!
Join the #1 Mushroom Newsletter/Community in North America today! 🍄🌞🤲
https://t.co/2jzR8vbIXP
Biomind Labs Doses First Subject in Phase I/IIa Clinical Trial of Its DMT-Based Inhaled Formulation BMND01 for Treatment-Resistant Depression $BMND $BMNDF
https://t.co/Jq5KotOwvp
PharmaTher Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Recent Business Highlights and Update $PHRM
https://t.co/vqLtuNnj0l
Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder $CYBN
https://t.co/43etNJE6s0